Enveloped viruses show increased propensity to cross-species transmission and zoonosis.

cross-species transmission viral emergence viral host breadth virus discovery zoonosis

Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
13 12 2022
Historique:
entrez: 6 12 2022
pubmed: 7 12 2022
medline: 15 12 2022
Statut: ppublish

Résumé

The transmission of viruses between different host species is a major source of emerging diseases and is of particular concern in the case of zoonotic transmission from mammals to humans. Several zoonosis risk factors have been identified, but it is currently unclear which viral traits primarily determine this process as previous work has focused on a few hundred viruses that are not representative of actual viral diversity. Here, we investigate fundamental virological traits that influence cross-species transmissibility and zoonotic propensity by interrogating a database of over 12,000 mammalian virus-host associations. Our analysis reveals that enveloped viruses tend to infect more host species and are more likely to be zoonotic than nonenveloped viruses, while other viral traits such as genome composition, structure, size, or the viral replication compartment play a less obvious role. This contrasts with the previous notion that viral envelopes did not significantly impact or even reduce zoonotic risk and should help better prioritize outbreak prevention efforts. We suggest several mechanisms by which viral envelopes could promote cross-species transmissibility, including structural flexibility of receptor-binding proteins and evasion of viral entry barriers.

Identifiants

pubmed: 36472956
doi: 10.1073/pnas.2215600119
pmc: PMC9897429
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2215600119

Commentaires et corrections

Type : CommentIn

Références

Microbiol Mol Biol Rev. 2008 Sep;72(3):457-70
pubmed: 18772285
Nature. 2017 Jun 29;546(7660):646-650
pubmed: 28636590
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7039-44
pubmed: 26038558
Lancet Microbe. 2020 May;1(1):e6-e7
pubmed: 32835320
Philos Trans R Soc Lond B Biol Sci. 2021 Nov 8;376(1837):20200358
pubmed: 34538140
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):
pubmed: 33822740
NAR Genom Bioinform. 2021 Feb 01;3(1):lqab004
pubmed: 33554119
Nat Rev Microbiol. 2015 Aug;13(8):461-9
pubmed: 26052667
Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):4170-5
pubmed: 27001840
Curr Biol. 2021 Aug 23;31(16):3671-3677.e3
pubmed: 34237267
Nat Rev Microbiol. 2017 Aug;15(8):502-510
pubmed: 28555073
Philos Trans R Soc Lond B Biol Sci. 2012 Oct 19;367(1604):2864-71
pubmed: 22966141
EMBO Rep. 2022 Aug 3;23(8):e55393
pubmed: 35848484
J Virol. 2017 Oct 27;91(22):
pubmed: 28878075
Philos Trans R Soc Lond B Biol Sci. 2001 Jul 29;356(1411):991-9
pubmed: 11516377
PLoS Biol. 2019 Apr 19;17(4):e3000217
pubmed: 31002666
Elife. 2018 Jan 16;7:
pubmed: 29336306
Nat Commun. 2022 Apr 1;13(1):1762
pubmed: 35365665
Science. 2018 Nov 2;362(6414):577-580
pubmed: 30385576
PLoS Biol. 2021 Sep 28;19(9):e3001390
pubmed: 34582436
mBio. 2022 Apr 26;13(2):e0298521
pubmed: 35229639
Sci Rep. 2015 Oct 07;5:14830
pubmed: 26445169
J Infect Dis. 2009 Feb 15;199(4):565-8
pubmed: 19281304
Science. 2018 Feb 23;359(6378):872-874
pubmed: 29472471
Nat Rev Microbiol. 2022 Jun;20(6):321-334
pubmed: 34983966
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):
pubmed: 33820825
Glob Ecol Biogeogr. 2020 Mar;29(3):470-481
pubmed: 32336945
Philos Trans R Soc Lond B Biol Sci. 2019 Sep 30;374(1782):20190296
pubmed: 31401961
PLoS Biol. 2021 Apr 20;19(4):e3001135
pubmed: 33878111
PLoS Pathog. 2017 Feb 8;13(2):e1006215
pubmed: 28178344
Microbiol Mol Biol Rev. 2015 Dec;79(4):403-18
pubmed: 26378223
Virology. 2018 Mar;516:108-114
pubmed: 29346073

Auteurs

Ana Valero-Rello (A)

Institute for Integrative Systems Biology, Consejo Superior de Investigaciones Científicas-Universitat de València 46980, Paterna, València, Spain.

Rafael Sanjuán (R)

Institute for Integrative Systems Biology, Consejo Superior de Investigaciones Científicas-Universitat de València 46980, Paterna, València, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH